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Abstract
If human papillomavirus (HPV) is necessary for the development of (pre)neoplastic lesions of the uterine cervix, it is not sufficient. Among the
cofactors involved in the malignant transformation of cells infected by HPV, sex hormones may facilitate the cervical carcinogenesis by different
mechanisms, including the induction of squamous metaplasia in the transformation zone of the cervix, interactions between steroid hormones and
HPV gene expression and alterations of the local immune microenvironment.
© 2006 Elsevier Ireland Ltd. All rights reserved.
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1. Introduction
Etiopathogenic and epidemiological studies have demon-
strated that viruses are etiologically linked to approximately
20% of all human malignancies worldwide (Blattner, 1999).
Although viruses alone are not sufficient to induce a complete
neoplastic transformation, they have been shown to be necessary
to promote and maintain the transformed state. With hepatitis
and Epstein Barr viruses, human papillomavirus (HPV) is one
of the best characterized virus associated with human cancer
diseases. HPV is a major pathogen involved in the malignant
transformation process of the skin and of ano-genital regions,
especially in the uterine cervix. Cervical cancer is the most
∗ Corresponding author. Tel.: +32 43662564; fax: +32 43662919.
E-mail address: P.Delvenne@ulg.ac.be (P. Delvenne).
common cancer in developing countries and the second most
common cancer in women worldwide (Mohar and Frias-
Mendivil, 2000). Specific types of human papillomaviruses
are strongly implicated as causative agents in the etiology of
cervical cancer and its precursors which are designated as cer-
vical intraepithelial neoplasia (CIN) or squamous intraepithelial
lesions (SILs). More than 20 HPV genotypes have been isolated
from the genital mucosa but only a limited number can be consid-
ered as high-risk viruses. HPV16 is the most frequently detected
HPV type in cervical cancer (Bosch et al., 1995). Whereas mor-
tality due to cervical cancer is highest in developing countries,
morbidity is also considerable in the industrialised world, where
direct and indirect costs from disease are very high.
Despite the evidence that human papillomavirus is strongly
implicated as the causative agent of cervical cancer, HPV infec-
tion alone is not sufficient for tumor development. In addition
to immune, microbial or chemical cofactors (de Vet and van
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Fig. 1. Schematic representation of the potential mechanisms by which sex
hormones may facilitate the cervical carcinogenesis: induction of squamous
metaplasia in the endocervical epithelium; alterations of antigen presenting cells
and increased HPV gene expression. HSIL: high-grade squamous intraepithelial
lesion; SCC: squamous cell carcinoma.
Leeuwen, 1986; Tindle, 2002), sex hormones may also play a
role in the development of (pre)neoplastic lesions of the uterine
cervix (Fig. 1). Indeed, the variation of hormonal status depend-
ing of age, pregnancy or contraceptive use has been shown to
influence the development of cervical (pre)cancers (Brisson et
al., 1994; Moreno et al., 2002; Munoz et al., 2002; Salazar et al.,
2001).
2. Role of sex hormones in the induction of squamous
metaplasia
A substantial majority of cancers and precursors lesions
(squamous intraepithelial lesions; SILs) develop within a
specific region of the cervix, the transformation zone (TZ)
(Burghardt and Ostor, 1983), where the glandular epithelium
of the endocervix is transformed progressively into a squamous
epithelium during a process called metaplasia. The TZ is hypoth-
esized to contain multipotent stem cells (or reserve cells) that
can give rise to both endocervical and ectocervical cell types.
Reserve cells are considered to be important in the evolution of
the TZ during reproductive years. Several lines of evidence sug-
gest that estrogen exposure is implicated in the hyperplasia and
squamous differentiation of reserve cells. First, squamous meta-
plasia appears to be induced in the cervix by a decreased pH and
epithelial acidification occurs during adolescence as a result of
increased estrogen production and vaginal bacterial flora alter-
ation. This acidosis may be a signal that contributes to a modified
fate decision of reserve cells (Elson et al., 2000). Secondly, it is
well known that estrogen treatment induces benign proliferation
of squamous epithelial cells in the cervix and vagina presumably
by signalling through the estrogen receptor (Lubahn et al., 1993).
In mouse models, it has been demonstrated that chronic estrogen
treatment of mice induces the development of extensive metapla-
sia with squamous/columnar cell junctions evident throughout
the entire cervical canal (Brake and Lambert, 2005). More-
over, administration of estrogen to 1-month-old mice results
in the conversion of the reserve cells to squamous epithelium
(Witkiewicz et al., 2005).
Interestingly, the topography and natural history of the human
TZ are also affected by age, hormonal status and parity (Buckley,
1994). For example, the mechanism by which the original
squamocolumnar junction changes location after the onset of
puberty may be due to swelling of the cervical stroma in
response to hormonal stimulation and pregnancy is associated
with more endocervical tissue moving out onto the ectocervix
(Hendrickson and Kempson, 1997). The influence of estrogen
exposure in the process of squamous metaplasia has also been
shown in human TZ tissues implanted in SCID mice (Tewari et
al., 2000).
Estrogen exposure is involved not only in the metaplas-
tic process but also in the particular sensitivity of the TZ to
the development of (pre)neoplastic lesions. Using K14-HPV16
transgenic mice in which the expression of HPV16 E6 and E7
oncogenes is driven by the keratin 14 promoter in the basal
keratinocytes of the squamous epithelium, some investigators
have shown that the TZ is five-fold more sensitive to the induc-
tion of squamous cell carcinogenesis by estrogen compared to
other sites of the reproductive tract (Elson et al., 2000). We
also found, by using immunohistological techniques and total
hysterectomy samples from young women undergoing surgery
for non-cervical benign uterine disease, that TZ biopsies with
immature squamous metaplasia exhibit a significantly higher
density of hormone receptor-positive cells compared to ectocer-
vical epithelium, suggesting that the TZ may be at increased risk
of developing (pre)neoplastic lesions because of a high sensitiv-
ity to sex hormone regulation (Remoue et al., 2003). Although
endometrial expression of estrogen and progesterone receptors
has been shown to vary during the menstrual cycle (Fujishita
et al., 1997; Ravn et al., 1994), no significant difference was
demonstrated in hormone receptor-positive cell density between
the follicular and luteal phases in both TZ and ectocervical biop-
sies (Remoue et al., 2003). These data are in agreement with
previous studies showing no significant variation, within the
menstrual cycle, in hormone receptor concentrations in vagi-
nal tissues (Schwartz, 2000) and in HPV-associated lesions
(Monsonego et al., 1991), suggesting a lower sensitivity to men-
strual cycle changes of genital squamous mucosa compared to
glandular endometrial tissues.
The expression of sex hormone receptors in human cervical
biopsies has also been shown to be higher in the precancerous TZ
compared to normal ectocervix and to increase with the grade
of SIL, strengthening the hormone-dependent establishment of
cervical (pre)neoplastic lesions (Monsonego et al., 1991).
Estrogen exposure may also contribute to the persistence and
malignant progression of cervical cancers. In the HPV transgenic
mice model, the continued growth and persistence of tumors
that have arisen in the reproductive tract of mice expressing the
viral oncogenes remained estrogen-dependent after their initial
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in human cervical cancer makes anti-estrogen therapy valu-
able (Brake and Lambert, 2005). Accordingly, the anti-estrogen
tamoxifen has been reported to induce progesterone receptors
and to inhibit cell growth in many human cervical carcinoma
cell lines (Vargas Roig et al., 1993). In a more recent study, aro-
matase expression was found in 35% of cervical tumor samples
and was proposed to contribute to tumor growth by increasing
cell proliferation and expression of growth or angiogenic fac-
tors such as VEGF (Nair et al., 2005), suggesting that in situ
estrogen production may influence the progression of gyneco-
logic malignancies in the absence of high levels of circulating
estrogen (Nair et al., 2005).
3. Role of sex hormones in HPV gene expression
The role of sex hormones during the cervical carcinogenesis
could be related not only to their ability to induce squamous
metaplasia but also to stimulate HPV gene expression through
hormone response elements in the viral genome (Yuan et al.,
1999). Interestingly, expression of estrogen receptor and HPV
oncogenes has been demonstrated in the same basal cell popula-
tion (Arbeit et al., 1996), suggesting that estrogen can enhance
transcription of HPV E6 and E7 oncogenes (Khare et al., 1997).
HPV E6 and E7 proteins of high-risk HPV are necessary for
cell transformation whereas the HPV E2 protein is required for
viral replication and gene expression (Blachon and Demeret,
2003). Interestingly, it was found that E2 and E7 proteins can
induce apoptosis in transformed cells (Cho et al., 2002; Demeret
et al., 2003; Desaintes et al., 1997; Webster et al., 2000) and
that progesterone and estrogen increase the levels of E2- and
E7-induced apoptosis (Webster et al., 2001). Although the mech-
anism is still not completely understood, the authors suggested
that the pro-apoptotic signals from E2 and E7 may be counter-
balanced by anti-apoptotic signals from HPV E6 protein. By
affecting this balance, steroid hormones can therefore decrease
cell growth. However, during the cervical carcinogenesis, HPV
DNA is often integrated into the host genome, leading to the loss
of E2 gene. Since HPV E2 is a modulator of HPV gene expres-
sion and, in the same time, an inducer of apoptosis, this loss
might increase cell proliferation (Sanchez-Perez et al., 1997;
Webster et al., 2000). In the presence of E2, progesterone and
estrogen might therefore protect cells from malignant transfor-
mation via upregulation of the cell death whereas, in the absence
of E2, these hormones might be a risk factor for the cervical car-
cinogenesis via their effects on HPV gene expression or other
still not identified pathways.
Other synergies may also exist between steroid hormones and
HPV in the pathogeny of cervical disease. Estrogen has a well-
known mitogenic activity (Liehr, 2000) which may be amplified
by viral oncoproteins. It has been shown to stimulate the pro-
liferation of human keratinocytes by promoting the expression
of cyclin D2 which induces G1 to S phase progression in the
cell cycle (Kanda and Watanabe, 2004). Estrogen also inhibits
oxidative stress-induced apoptosis in keratinocytes by promot-
ing expression of the anti-apoptotic protein bcl-2 (Kanda and
Watanabe, 2003). Estrogen can also induce direct DNA dam-
age via its catechol metabolites (Newfield et al., 1998; Zhu and
Conney, 1998) and HPV infection has been shown to markedly
increase the formation of these potentially carcinogenic estrogen
metabolites (Auborn et al., 1991).
4. Role of sex hormones on the cervical immune
microenvironment
In addition to interactions between sex hormones and HPV
gene expression, hormones could also sensitise the TZ to
cervical cancer formation by altering the local immune microen-
vironment. The squamous epithelium of the cervix is composed
not only of keratinocytes (the primary target of HPV) but also
of a type of immature dendritic cell (DC), the Langerhans cells
(LC), which are important for the immunosurveillance of the
squamous epithelium (Romani et al., 2003). Interestingly, the
density of LC and their function are significantly reduced in the
TZ compared to the ectocervix (Al-Saleh et al., 1995; Giannini
et al., 2002), suggesting that keratinocyte/DC interactions could
play a role in the establishment of SIL in this region. The
production of cytokines/chemokines is necessary to maintain
a balanced turnover of LC (Griffiths et al., 2005) and is most
likely influenced by the complex differentiation state of ker-
atinocytes, which is altered in metaplastic areas of the TZ and
during cervical carcinogenesis (Hubert et al., 1999; Smedts et
al., 1992).
There is now accumulating evidence that sex hormones have
the property to influence the immune system, particularly by
acting on cytokine production (Gilmore et al., 1997; McMurray
et al., 2001; Rogers and Eastell, 2001; Schuurs and Verheul,
1990). For example, progesterone has been shown to increase
the production of IB, an inhibitor of NFB (Miller and Hunt,
1998) and to have an inhibitory effect on GM-CSF secretion
(Robertson et al., 1996). Estradiol has been also reported to
inhibit the expression of GM-CSF in the U2OS cell line via
interaction with estrogen receptor alpha (Er) and to decrease
this production via contact with ER (Brady et al., 2002).
Sex hormones may also directly influence DC/LC by mod-
ulating their morphology, density, distribution, maturity and
function (Kaushic et al., 1998; Komi et al., 2001; Koyama
et al., 1989; Wira et al., 2000; Young and Hosking, 1986).
More specifically, sex hormones have been shown to influence
the distribution of DC in the epithelium of rat reproductive
tract (Kaushic et al., 1998). 17-estradiol inhibits antigen pre-
sentation and decreases the number of LC in ovariectomized
rodents. In contrast, progesterone given together with 17-
estradiol reverses the inhibitory effect of estradiol on antigen
presentation and increases the number of LC in ovariectomized
rodents (Wira and Rossoll, 1995). Progesterone is also able
to increase the number of LC in human vaginal epithelium
(Hubert et al., 2001; Wieser et al., 2001). In a context of
autoimmune encephalomyelitis, it has been demonstrated that
the pretreatment of DC with estradiol suppresses their ability
to present antigens to specific T cells (Zhang et al., 2004).
Analysis of cytokine production demonstrated that estradiol
decreases TNF, IFN and IL-12 production by immature DC
(Liu et al., 2002). In addition, estrogen-exposed DC prevents
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regulatory T cells producing IL-10 and of CD4+CD28+ sup-
pressor T cells (Pettersson et al., 2004). Moreover, specific T
cells cocultured with estradiol-pretreated mature DC in the pres-
ence of antigens exhibit a shift towards a production of type II
cytokines such as IL4 and IL10 (Liu et al., 2002). Interestingly,
a co-expression of IL10 and IL4 has been demonstrated in estab-
lished (pre)neoplasic lesions of the cervix (Al Saleh et al., 1998;
Giannini et al., 1998) and suggests the presence of a type II
cytokine pattern instead of a cell-mediated anti-tumor immu-
nity. This inappropriate response against intracellular infectious
agents, such as viruses or tumor cells may lead to the persistence
of HPV by preventing infected cells from being eliminated by
cytotoxic T lymphocytes.
In conclusion, epidemiological, experimental, virological
and immunological data suggest that sex hormones play a role,
in addition to HPV infection, in the development of cervical
HPV infections and associated (pre)neoplastic lesions. These
observations may be relevant for studies aiming to develop new
anti-neoplastic therapeutic or preventive strategies.
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